DrugDashboards

Tpoxx

tecovirimat monohydrate · TECOVIRIMAT MONOHYDRATE 200 mg/1 · Capsule · Oral · SIGA Technologies, Inc.

NDC 50072-0200-42 · 42 CAPSULE in 1 BOTTLE · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA208627
TE code
Approval date
Jul 13, 2018
Patents / exclusivity
5 patents, 0 exclusivities
TypeNumber / codeExpires
patent11890270Aug 8, 2032
patent7737168Sep 4, 2031
patent9339466Mar 23, 2031
patent12433868Mar 23, 2031
patent8039504Jul 23, 2027

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of tecovirimat monohydrate (Capsule)

LabelerStrengthFirst seenLast seen
SIGA Technologies, Inc.TECOVIRIMAT MONOHYDRATE 200 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Tpoxx — NDC 50072-0200-42," retrieved September 3, 2026, https://drugdashboards.com/drug/50072020042.

Free to cite with attribution — see how the data is put together.